Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer | MicrobiomeTrials← Back to trialsNCT06495346
Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
CompletedOBSERVATIONAL
Trial Details
Start: 2023-12-11Est. Completion: 2025-03-25
Enrollment target: 37 participants Locations- HUS, Strasbourg, Grand Est, France
Other microbiome trials you might be interested in
Cancer (Advanced Stage)
This single-site, randomized pilot study will evaluate whether intermittent fasting is feasible and safe for patients wi…
Multiple LocationsEst. completion Feb 2029
Advanced Extrapulmonary Neuroendocrine CarcinomaMetastatic Extrapulmonary Neuroendocrine CarcinomaRecurrent Extrapulmonary Neuroendocrine CarcinomaUnresectable Extrapulmonary Neuroendocrine Carcinoma
This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy…
Anchorage, United StatesEst. completion Oct 1, 2028
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)Triple -Negative Breast CancerPancreas Adenocarcinoma
Single-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerabili…
Rome, ItalyEst. completion May 1, 2027